Abstract. Binding of 125I-insulin-like growth factor-I and 125I-ovine somatomedin-C/IGF-I to monolayer cultures of muscle-derived ovine fibroblasts is described.
Preliminary competitive binding experiments indicate that ovine fibroblasts possess independent cell surface receptors for IGF-I. Affinity of rIGF-II for IGF-I binding sites is minimal; rIGF-II binds to Type I IGF receptors at 1/1000 the strength of IGF-I. Insulin binds to the Type I IGF receptor at 1/100 the strength of IGF-I, whereas ovine somatomedin-C/IGF-I displays equivalent IGF-I binding as evidenced by overlapping competition of ovine somatomedin-C/IGF-I for 125I-IGF-I binding sites. Results from disuccinimidyl suberate cross-linking of 125I-IGF-I to muscle-derived ovine fibroblasts in the presence of related polypeptides verified the competitive binding data. Under reducing conditions, 125I-IGF-I: receptor complexes migrated to a relative molecular weight of approximately 135 000 daltons. Specific 125I-IGF-I binding was completely inhibited by 10\m=-\8mol/l IGF-I, 7.2 \m=x\10\m=-\8mol/l ovine somatomedin-C/IGF-I, and 10\m=-\6mol/l insulin and partially inhibited by 7.2 \m=x\10\m=-\9 mol/l ovine somatomedin-C/IGF-I and 6.5 \m=x\10\m=-\8 mol/l rIGF-II. 125I-ovine somatomedin-C/IGF-I : receptor complexes also migrated at a relative molecular weight of 135 000 daltons. No migratory band was observed at 250 000 to 260 000 daltons with either 125I-IGF-I or 125I-ovine somatomedin-C/IGF-I indicating that little labelled moiety bound to the Type II IGF receptor. Based on these preliminary competitive binding studies and cross-linking data, we conclude that ovine somatomedin-C/IGF-I is primarily interacting with the Type I IGF membrane receptor on ovine skeletal muscle fibroblasts.
Insulin-like growth factors somatomedins com¬ prise a family of polypeptides (Perdue 1984; Froesch & Zapf 1985) with similar structure (Froesch & Zapf 1985) and biological activities (Myal et (Nissley et al. 1985) . Because of these differences, competitive binding (Rechler et al. 1983 ) and bifunctional affinity labelling (Oppenheimer & Czech 1984) methods have been used to distinguish the two types of receptors.
Knowledge of IGF receptor binding properties has been used initially to characterize an IGF preparation isolated from ovine serum . Indeed, biological characterization of ovine somatomedin-C/IGF-I revealed that this moiety promoted cell proliferation in a manner consistent with IGF-I (Dodson et al. 1985 (Dodson et al. 1987) , and allowed to proliferate to 90% confluency. First through eighth-passage fibroblasts were used for these studies. (Miskimins & Shimizu 1984 ) to a specific activity of 70 to 100 µ µ%. Highly purified ovine somatomedin-C/IGF-I was iodin¬ ated to a specific activity of 90 to 100 µCi/µg using the lacto-peroxidase technique (Thorell 8c Johnson 1971).
Binding of radiolabelled IGF-I, or ovine somatomedin-C/IGF-I, in the presence of competitive antagonists was conducted on whole fibroblasts as similarly described (Shimizu & Shimizu 1980 
Results
Binding of radiolabelled 125I-IGF-I to musclederived ovine fibroblasts in the presence of re¬ lated polypeptides is presented in Fig. 1 
Discussion
The presence of somatomedin-like molecules in domestic animals has been well established. Bovine serum possesses two somatomedin-like moitiés: one that is structurally identical to human IGF-I and one that is similar to IGF-II in function (Honegger & Humbel 1986 ). Radioimmunoassay and radioreceptor data have suggested that ovine serum contains both an IGF-I like polypeptide (Wilson & Hintz 1982) and an IGF-II like moiety (Zangger et al. 1987) . Ovine somatomedin-C/IGF-I, however, represents the only reported ovine somatomedin-like moiety that has been isolated and initially characterized in vitro. This polypep¬ tide has a molecular size of 6900 daltons and promotes proliferation of myogenic satellite cells in a manner more similar to IGF-I than IGF-II (Dodson et al. 1985) .
Preliminary data indicate that ovine somatome¬ din-C/IGF-I binds to (Dodson et al., unpublished data) and acts through (Dodson et (Nissley et al. 1985) . The crosslinking results presented in Fig. 3 
